Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
tegretol 200 mg
novartis norge (2) - karbamazepin - tablett - 200 mg
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
tegretol 20 mg/ ml
novartis norge (2) - karbamazepin - mikstur, suspensjon - 20 mg/ ml
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
tegretol 100 mg
novartis norge (2) - karbamazepin - tablett - 100 mg
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
tegretol retard 400 mg
novartis norge (2) - karbamazepin - depottablett - 400 mg
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
tegretol retard 200 mg
novartis norge (2) - karbamazepin - depottablett - 200 mg
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
trimonil retard 300 mg
orifarm as - karbamazepin - depottablett - 300 mg
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
trimonil retard 300 mg
orifarm as - karbamazepin - depottablett - 300 mg
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
zebinix 800 mg
orifarm as - eslikarbazepinacetat - tablett - 800 mg
Եվրոպական Միություն -
Նորվեգերեն -
EMA (European Medicines Agency)
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
Նորվեգիա -
Նորվեգերեն -
Statens legemiddelverk
briviact 75 mg
2care4 aps - brivaracetam - tablett, filmdrasjert - 75 mg